Delivery Order SPE2DB22D2214-SPE2DB25FS2RB
Award Date
11/4/24
Potential Completion Date
11/5/24
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB24D1104|SPE2DB25FXXA5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,432.27 contract, awarded on January 29, 2025, is a firm-fixed-price delivery order for AIMOVIG 140 MG/ML AUTOINJECTORML and has an ultimate completion date of January 30, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, identified as SPE2DB20D2104|SPE2DB25F1126, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,715.72, is for the delivery of 4566401471 AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. It is not designated...
This federal contract award, identified as SPE2DB22D2214|SPE2DB25FS3EK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,052.89, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a firm fixed price and is set to expire on December 31, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
The federal contract award, SPE2DB20D2104|SPE2DB25FMKTF, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,957.34 firm fixed price delivery order is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. Amerisourcebergen holds a significant $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,631.27 contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication, to an undisclosed location in Conshohocken, Pennsylvania. The contract has a completion date of July 2, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a substantial...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, through its Corporate Office division located in Conshohocken, Pennsylvania. The award, valued at $1,885.24, is a firm fixed price delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 3, 2024....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML to the Defense Logistics Agency (DLA). The $2,461.44 Firm Fixed Price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award, valued at $12,441.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product, with a completion date of November 7, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award, SPE2DB22D1106|SPE2DB25FEKY2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,313.54 firm fixed-price delivery order is for the supply of the medication AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $67,866.01, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2025 and is a firm-fixed-price delivery order with no set-aside designation, indicating open...